Clinical efficacy of Rasona Pinda in the management of Amavata (rheumatoid arthritis)
- PMID: 22131727
- PMCID: PMC3221059
- DOI: 10.4103/0974-8520.77149
Clinical efficacy of Rasona Pinda in the management of Amavata (rheumatoid arthritis)
Abstract
In the present clinical study, 63 patients of Amavata were registered from the Kayachikitsa out patient department/indoor patient department (OPD/IPD) of Sir Sunder Lal Hospital (Indian Medicine Wing), IMS, BHU, Varanasi-5. In group I (Rasona Pinda), 27 patients completed the study of a total of 33patients registered in the group (six patients dropped out mid-therapy). In group II (control group), 23 patients completed all three follow-ups out of 30 patients (there were seven dropouts in mid-therapy). In group I, complete remission in 29.6%, major improvement in 59.3% and minor improvement in change font so as to appear 11.1% were observed. In group II, complete remission in 13%, major improvement in 21.7%, minor improvement in 39.1% and unchanged in 26.9% of the patients were observed.
Keywords: Agni; Ama; Amavata; Rasona Pinda; Rheumatoid Arthritis; Visual Analog Scale.
Figures
References
-
- Bunch TW, O Duff JD. Disease modifying drugs for progressive rheumatoid arthritis. Mayo Clin Proc. 1980;55:161–5. - PubMed
-
- Clive DM, Stoff JS. Renal syndromes associated with non-steroidal anti- inflammatory drugs. N Engl J Med. 1984;310:563–72. - PubMed
-
- O’Duff JD, Luthra HS. Current status of disease modifying drugs in progressive rheumatoid arthritis. Drugs. 1984;27:373–7. - PubMed
-
- Mishra B S, editor. Amavatarogadhikar-26. Varanasi: Madhyamkhand Chaukhamba Bharati Academy; 2001. Bhavprakash, Bhavprakash Uttrarardh Vidyotini.
